TransMedics (TMDX) Income from Continuing Operations (2018 - 2026)
TransMedics' (TMDX) quarterly Income from Continuing Operations came in at 7315000.0 in Q1 2026, down 71.51% year-on-year from 25676000.0 in Q1 2025, and down 94.14% quarter-over-quarter from 124933000.0 in Q4 2025.
TransMedics (TMDX) Income from Continuing Operations (2018 - 2026) Analysis & Trends
TransMedics' Income from Continuing Operations history runs 9 years deep, the most recent figure standing at 7315000.0 for Q1 2026.
- On a quarterly basis, Income from Continuing Operations fell 71.51% year-over-year to 7315000.0 in Q1 2026; TTM through Mar 2026 was 191449000.0, a 1303.48% increase from a year earlier, with the FY2025 full-year figure at 190322000.0, up 130257.53% from the prior year.
- Income from Continuing Operations slipped to 7315000.0 in Q1 2026 per TMDX's latest filing, from 124933000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 124933000.0 in Q4 2025 and bottomed at 28445000.0 in Q4 2024.
- The 5-year median for Income from Continuing Operations is 1996000.0 (2023), against an average of 9058411.76.
- Biggest YoY gain for Income from Continuing Operations was 1318.18% in 2024; the steepest drop was 1525.1% in 2024.
- Year by year, Income from Continuing Operations stood at 6720000.0 in 2022, then surged by 129.7% to 1996000.0 in 2023, then plunged by 1525.1% to 28445000.0 in 2024, then jumped by 539.21% to 124933000.0 in 2025, then tumbled by 94.14% to 7315000.0 in 2026.
- Per Business Quant, the three latest TMDX Income from Continuing Operations figures stand at 7315000.0 (Q1 2026), 124933000.0 (Q4 2025), and 24319000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | TransMedics | 2.45 Bn | 1.98 Bn | 101.16 Mn | 7.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.32 Mn |
| Dec 31, 2025 | 124.93 Mn |
| Sep 30, 2025 | 24.32 Mn |
| Jun 30, 2025 | 34.88 Mn |
| Mar 31, 2025 | 25.68 Mn |
| Dec 31, 2024 | -28.45 Mn |
| Sep 30, 2024 | 4.22 Mn |
| Jun 30, 2024 | 12.19 Mn |
| Mar 31, 2024 | 12.20 Mn |
| Dec 31, 2023 | 2.00 Mn |
| Sep 30, 2023 | -25.42 Mn |
| Jun 30, 2023 | -1.00 Mn |
| Mar 31, 2023 | -2.64 Mn |
| Dec 31, 2022 | -6.72 Mn |
| Sep 30, 2022 | -7.43 Mn |
| Jun 30, 2022 | -11.52 Mn |
| Mar 31, 2022 | -10.56 Mn |
| Dec 31, 2021 | -12.81 Mn |
| Sep 30, 2021 | -12.96 Mn |
| Jun 30, 2021 | -10.67 Mn |